ArticleFrontiers in immunology2021

Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab.

Michael Gernert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.